Methods and Compositions for Treating Non-Hematologic Cancer
US Application 62/403,889
Filed on 2016-10-04
Filed on 2016-10-04
Methods and Compositions for Treating Non-Hematologic Cancer
US Application 62/400,609
Filed on 2016-09-27
Filed on 2016-09-27
HLA CLASS I-RESTRICTED T CELL RECEPTORS AGAINST MUTATED RAS
US Application 62/594,244
Filed on 2017-12-04
Filed on 2017-12-04
METHODS OF ENRICHING CELL POPULATIONS FOR CANCER-SPECIFIC T CELLS USING IN VITRO STIMULATION OF MEMORY T CELLS
US Application 62/594,262
Filed on 2017-12-04
Filed on 2017-12-04
STEREOSELECTIVE SYNTHESIS AND PROCESS FOR THE MANUFACTURING OF 2'-DEOXYNUCLEOSIDES
US Application 62/624,967
Filed on 2018-02-01
Filed on 2018-02-01
METHODS OF ISOLATING T CELLS HAVING ANTIGENIC SPECIFICITY FOR A P53 CANCER-SPECIFIC MUTATION
US Application 62/565,464
Filed on 2017-09-29
Filed on 2017-09-29
T CELL RECEPTORS RECOGNIZING MUTATED P53
US Application 62/565,383
Filed on 2017-09-29
Filed on 2017-09-29
TREATING OR PREVENTING ADVERSE LIVER CONDITIONS BY ADMINISTERING A PRIMARY BILE ACID
US Application 62/578,176
Filed on 2017-10-27
Filed on 2017-10-27
ANTI-CANCER ACTIVITY OF SCGB3A2 AND LPS
US Application 62/619,511
Filed on 2018-01-19
Filed on 2018-01-19
IMMUNOTOXINS WITH ALBUMIN BINDING DOMAIN
US Application 62/559,926
Filed on 2017-09-18
Filed on 2017-09-18